Shareholders’ Association slams ‘shameful’ Ebos capital raise
Healthcare and pharma company accused of ignoring its retail investors.
Wed, 01 May 2019
The NZ Shareholders’ Association is describing the oversubscribed $175 million capital raise by conglomerate Ebos as “19th-century governance in the 21st century.”
Initially Ebos hoped to raise $150m by issuing approximately 7.7 million shares at $19.70 a share, representing a discount of
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
